Hiroya Tamai

9PUBLICATIONS
28CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Clinical social work practiceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 05, 2026
Association of genetic variants with extravascular complications and cytokine production in Takayasu arteritis: a cross-sectional study.

Farzana Shumy, Kotaro Matsumoto, Masaru Takeshita

|Apr 01, 2025
Achievement and Usefulness of Intermediate Treatment Targets for Still Disease Proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society.

Hiroya Tamai, Sora Ito, Satoshi Takanashi

|Mar 26, 2024
Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.

Hiroto Yoshida, Mayu Magi, Hiroya Tamai

|Mar 20, 2024
Tocilizumab discontinuation after remission achievement in patients with adult-onset Still's disease.

Hiroya Tamai, Yasushi Kondo, Tsutomu Takeuchi

|Sep 27, 2022
Serum cytokines and bone metabolic markers in patients with rheumatoid arthritis treated with biological disease modifying anti-rheumatic drugs.

Hiroya Tamai, Naoshi Nishina, Jun Kikuchi

|Mar 12, 2021
Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.

Eiichi Tanaka, Yutaka Kawahito, Masataka Kohno

Pageof 2

Frequent Collaborators

3 joint publications

Yuko Kaneko

2 joint publications

Tsutomu Takeuchi

2 joint publications

Shintaro Hirata

2 joint publications

Hiroto Yoshida